ICD-10 Coding for Human Papillomavirus(B97.7U, R87.611U, R87.810)
Comprehensive guide on ICD-10 coding for Human Papillomavirus (HPV), including screening, vaccination, and documentation requirements.
Complete code families applicable to Human Papillomavirus
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Z11.51 | Encounter for screening for human papillomavirus (HPV) | Use for routine HPV screening encounters. |
|
| R87.810 | Cervical high-risk human papillomavirus (HPV) DNA test positive | Use when high-risk HPV DNA is detected in cervical specimens. |
|
| Z23 | Encounter for immunization | Use for encounters where HPV vaccination is administered. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHuman Papillomavirus
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Human Papillomavirus.
Omitting HPV type in documentation
Impact
Clinical: May affect patient management decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials due to incomplete information.
Mitigation
Always document HPV type if available.
Using Z11.51 for diagnostic testing
Impact
Reimbursement: Incorrect coding may lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate health data reporting.
Mitigation
Use R87.810 for positive HPV test results.
HPV Screening Documentation
Impact
Inadequate documentation for HPV screening encounters.
Mitigation
Ensure all screening details are documented, including test type and results.